Tanei, T., Yamamoto, S., Maesawa, S., Nishimura, Y., Ishizaki, T., Nagashima, Y., . . . Saito, R. Identifying Factors Associated with the Efficacy of Lasmiditan 50 mg as an Acute Treatment for Migraine Attacks Under Various Dosing Conditions in Real-World Clinical Practice. MDPI AG.
Chicago Style (17th ed.) CitationTanei, Takafumi, et al. Identifying Factors Associated with the Efficacy of Lasmiditan 50 Mg as an Acute Treatment for Migraine Attacks Under Various Dosing Conditions in Real-World Clinical Practice. MDPI AG.
MLA (9th ed.) CitationTanei, Takafumi, et al. Identifying Factors Associated with the Efficacy of Lasmiditan 50 Mg as an Acute Treatment for Migraine Attacks Under Various Dosing Conditions in Real-World Clinical Practice. MDPI AG.
Warning: These citations may not always be 100% accurate.